SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-12-000088
Filing Date
2012-11-19
Accepted
2012-11-19 17:19:34
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 PHARMOS QUARTERLY REPORT pars10q09302012.htm 10-Q 361349
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex311.htm EX-31.1 9432
3 SECTION 1350 CERTIFICATION ex321.htm EX-32.1 5210
  Complete submission text file 0001513160-12-000088.txt   1330751

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pars-20120930.xml EX-101.INS 93188
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pars-20120930.xsd EX-101.SCH 13970
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20120930_cal.xml EX-101.CAL 23480
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pars-20120930_def.xml EX-101.DEF 8799
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pars-20120930_lab.xml EX-101.LAB 86182
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pars-20120930_pre.xml EX-101.PRE 62242
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

IRS No.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11550 | Film No.: 121215604
SIC: 2834 Pharmaceutical Preparations